Drug induced ototoxicity is defined as damage to the Cochlea and vestibule caused by the use or exposure to certain therapeutic or chemical drugs Common OTOTOXIC drugs are: aminoglycoside antibiotics, salicylic acid, quinine and loop diuretics, anti-tumor chemotherapy drugs.
This report contains market size and forecasts of Drug Induced Ototoxicity Treatment in Global, including the following market information:
Global Drug Induced Ototoxicity Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug Induced Ototoxicity Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alternative Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Induced Ototoxicity Treatment include Advanced Bionics, Pfizer, Otonomy, Eli Lilly and Company, Sound Pharmaceuticals, WellSpring Pharmaceutical Corporation, Hoffmann-La Roche, Teva Pharmaceuticals and GlaxoSmithKline and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Induced Ototoxicity Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Induced Ototoxicity Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Induced Ototoxicity Treatment Market Segment Percentages, by Type, 2021 (%)
Alternative Therapies
Medications
Hearing Aids
Cochlear Implants
Assistive Listening Devices (ALD’s)
Global Drug Induced Ototoxicity Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Induced Ototoxicity Treatment Market Segment Percentages, by Application, 2021 (%)
Cochlear Drug-Induced Ototoxicity
Vestibular Drug-Induced Ototoxicity
Global Drug Induced Ototoxicity Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Induced Ototoxicity Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Induced Ototoxicity Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug Induced Ototoxicity Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Bionics
Pfizer
Otonomy
Eli Lilly and Company
Sound Pharmaceuticals
WellSpring Pharmaceutical Corporation
Hoffmann-La Roche
Teva Pharmaceuticals
GlaxoSmithKline
Sonova Holding